|4Apr 23, 5:04 PM ET

Accelmed Growth Partners (AGP) Ltd 4

4 · COGENTIX MEDICAL INC /DE/ · Filed Apr 23, 2018

Insider Transaction Report

Form 4
Period: 2018-04-20
Transactions
  • Disposition from Tender

    Common Stock, $0.01 par value per share

    2018-04-20$3.85/sh16,129,033$62,096,7770 total
Footnotes (2)
  • [F1]On April 20, 2018, these shares were purchased in a tender offer for all of the issued and outstanding shares of common stock, par value $0.01 per share, of Cogentix Medical, Inc. (the Company") by Camden Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of LM US Parent, Inc. and Laborie Medical Technologies Canada ULC, pursuant to the Agreement and Plan of Merger dated as of March 11, 2018 (the "Merger Agreement").
  • [F2]These shares are held directly by Accelmed Growth Partners, L.P. and may be deemed to be beneficially owned indirectly by (i) Accelmed Growth Partners (GP), L.P., the general partner of Accelmed Growth Partners, L.P., (ii) Accelmed Growth Partners (AGP) Limited, the general partner of Accelmed Growth Partners (GP), L.P., and (iii) Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares pursuant to a management agreement. Each of Accelmed Growth Partners (GP), L.P., Accelmed Growth Partners (AGP) Limited, and Accelmed Growth Partners Management Ltd. disclaims such beneficial ownership except to the extent of its pecuniary interest in the shares.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4